There was always uncertainty in the recovery of ZnO sales.
But I want to know more about this:
What is 'significantly'? To which industries? Is this just Merck ramping up sales, or is there now traction in the non-cosmetic area?
Alusion has great upside, and it's possible that mid-next year we're seeing a ZnO sales recovery, alongside a boom in Alusion. But that does make a number of assumptions.
Ann: COVID-19 Sales Update, page-12
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ANO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
72.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.96M | |||
| Open | High | Low | Value | Volume |
| 72.0¢ | 73.0¢ | 72.0¢ | $2.378K | 3.303K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 53514 | 72.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.0¢ | 4981 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| ANO (ASX) Chart |